MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Notoginsenoside R1

CAS No. : 80418-24-2

MCE 国际站：Notoginsenoside R1

产品活性：Notoginsenoside R1 (Sanchinoside R1)，是一种从 P. notoginseng 中分离出来的皂苷。 Notoginsenoside R1 具有抗氧化，抗炎，抗血管生成和抗凋亡的活性。Notoginsenoside R1 可提供抗缺血/再灌注 (I/R) 损伤的心脏保护作用。Notoginsenoside R1 还可以提供神经保护作用。

研究领域：Neuronal Signaling | Apoptosis

作用靶点：Amyloid-β | Apoptosis

In Vitro: Notoginsenoside R1 (2.5-80 µM; 24 h) inhibits the hypoxia-reoxygenation (H/R)-induced cell death, intracellular ROS accumulation, and mitochondrial membrane depolarization in H9c2 cardiomyocytes.
Notoginsenoside R1 (5-20 µM; 24 h) inhibits the H/R-induced H9c2 cardiomyocytes apoptosis in a concentration-dependent manner.
Notoginsenoside R1 (1-100 µM; 24 h) dose-dependently protects PC12 cells and primary neurons from Aβ-induced cell death and apoptosis.
Notoginsenoside R1 (10 µM; 24 h) inhibits Aβ_25-35-induced ROS production, mitochondrial damage and MAPK activation in PC12 cells.

In Vivo: Notoginsenoside R1 (5 mg/kg/h; infused via the right jugular vein) increases red blood cell velocity, reduces the number of adherent leukocytes and inhibits mast cell degranulation and cytokine elevation in rats.

相关产品：Natural Product Library Plus | Bioactive Compound Library Plus | Apoptosis Compound Library | Neuronal Signaling Compound Library | Natural Product Library | Medicine Food Homology Compound Library | Terpenoids Library | Traditional Chinese Medicine Monomer Library | FDA Approved & Pharmacopeial Drug Library | Anti-Alzheimer’s Disease Compound Library | Neuroprotective Compound Library | MG-132 | LY294002 | Doxorubicin hydrochloride | Bafilomycin A1 | Paclitaxel | Y-27632 dihydrochloride | Acetylcysteine | Angiotensin II human | Deferoxamine mesylate | SP600125 | 5-Fluorouracil | Staurosporine | Bortezomib | Tamoxifen | 2-Deoxy-D-glucose | Gemcitabine | Verteporfin | Decitabine | Actinomycin D | Temozolomide | BAY 11⁻⁷082 | Etoposide | Mitomycin C | CCCP | DAPT | Rotenone | Etomoxir | Stattic | Docetaxel

品牌介绍:
• MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；
• 10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
• 设有专业的实验中心和严格的质控、验证体系；
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
• 产品的生物活性多经各国客户实验验证；
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；
• 专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；
• 与世界各大制药公司及知名科研机构建立了长期的合作。